Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2023 Sep-Oct;73(5):665-675.
doi: 10.1016/j.bjane.2022.07.005. Epub 2022 Jul 30.

Dexmedetomidine versus clonidine as an adjuvant to local anaesthetic in brachial plexus blocks: a meta-analysis of randomised controlled trials

Affiliations
Review

Dexmedetomidine versus clonidine as an adjuvant to local anaesthetic in brachial plexus blocks: a meta-analysis of randomised controlled trials

Vijeta Bajpai et al. Braz J Anesthesiol. 2023 Sep-Oct.

Abstract

Objective: This meta-analysis aimed to compare the efficacy and safety of dexmedetomidine and clonidine as an adjuvant to local anesthetics in BPBs.

Methods: Two investigators independently searched databases to identify all RCTs comparing the efficacy and/or safety of dexmedetomidine and clonidine as an adjuvant to local anesthetics in BPBs. All outcomes were pooled using the inverse variance method with a random-effect model. An I2 test was used to assess heterogeneity. The source of heterogeneity was explored through meta-regression. The quality of the evidence was assessed using the GRADE approach.

Results: Out of 123 full texts assessed, 24 studies (1448 patients) were included in the analysis. As compared to clonidine, dexmedetomidine groups showed significantly longer sensory block duration (MD = 173.31; 95% CI 138.02‒208.59; I2 = 99%; GRADE approach evidence: high); motor block duration (MD = 158.35; 95% CI 131.55‒185.16; I2 = 98%; GRADE approach evidence: high), duration of analgesia (MD = 203.92; 95% CI 169.25‒238.58; I2 = 99%; GRADE approach evidence- high), and provided higher grade quality of block (RR = 1.97; 95% CI 1.60‒2.41; I2 = 0%; GRADE approach evidence: moderate). The block positioning technique (regression coefficient: 51.45, p = 0.005) was observed as a significant predictor of the heterogeneity in the case of sensory block duration. No significant difference was observed for the risk of hypotension (RR = 2.59; 95% CI 0.63‒10.66; I2 = %).

Conclusion: Moderate to high-quality evidence suggests dexmedetomidine is a more efficacious adjuvant to local anesthetic in BPBs than clonidine.

Keywords: Brachial plexus block; Clonidine; Dexmedetomidine; Meta-analysis.

PubMed Disclaimer

Conflict of interest statement

Conflicts of interest The authors declare no conflicts of interest.

Figures

Figure 1
Figure 1
Prisma flow diagram showing the study selection process.
Figure 2
Figure 2
Meta-analytic summary of the sensory block duration through a random effect model.
Figure 3
Figure 3
Meta-analytic summary of the motor block duration through a random effect model.
Figure 4
Figure 4
Meta-analytic summary of the duration of analgesia through a random effect model.

Similar articles

Cited by

References

    1. Fischer HBJ. Churchill Livingstone; London: 2003. Brachial plexus anaesthesia. In principles and practice of regional anaesthesia; pp. 193–204. Wildsmitis JAW, Armitage EN, Mc Clure JH, editors, third edition.
    1. Damien B, Murhy Collin JL, Cartney Vincent WS. Novel analgesic adjuvants for brachial plexus block: A systemic review. Anesth Analg. 2000;90:1122–1128. - PubMed
    1. El-Hennawy AM, Abd-Elwahab AM, Abd-Elmaksoud AM, El-Ozairy HS. Addition of Clonidine or Dexmedetomidine to bupivacaine prolongs caudal analgesia in children. Br J Anaesth. 2009;103:268–274. - PubMed
    1. Popping DM, Elia N, Marret E, Wenk M, Tramèr MR. Clonidine as an adjuvant to local anaesthetic for peripheral nerve and plexus blocks: A meta-analysis of randomized trials. Anesthesiology. 2009;111:406–415. - PubMed
    1. Virtanein R, Savola JM, Saanov Nyman L. Characterization of the selectivity, specificity, and potency of dexmedetomidine as an alpha -2 adrenoceptor. Eur J Pharmacol. 1998;150:194. - PubMed